(Q47315208)

13 January 2018

title

Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system (English)

1 reference

13 January 2018

1 reference

1 reference

2

1 reference

13 January 2018

Jan Adolfsson

4

1 reference

13 January 2018

author name string

Meikle AW

1

1 reference

13 January 2018

Dobs AS

3

1 reference

13 January 2018

Sanders SW

5

1 reference

13 January 2018

Middleton RG

6

1 reference

13 January 2018

Stephenson RA

7

1 reference

13 January 2018

Hoover DR

8

1 reference

13 January 2018

Rajaram L

9

1 reference

13 January 2018

Mazer NA

10

1 reference

13 January 2018

language of work or name

English

0 references

publication date

1 February 1997

1 reference

13 January 2018

published in

Urology

1 reference

13 January 2018

volume

49

1 reference

13 January 2018

issue

2

1 reference

13 January 2018

page(s)

191-196

1 reference

13 January 2018

Hormonal therapy of male hypogonadism.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Transdermal dihydrotestosterone treatment of 'andropause'.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Benign Prostatic Hyperplasia: Antecedents and Natural History

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Effects of age, sex steroids, and family relationships on volumes of prostate zones in men with and without prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

The development of human benign prostatic hyperplasia with age

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Testosterone secretion and metabolism in male senescence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

1 reference

7 January 2021

Ultrasound monitoring of testis and prostate maturation in hypogonadotropic hypogonadic males during gonadotropin-releasing hormone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Changes in the pituitary-testicular system with age.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Production, clearance, and metabolism of testosterone in men with prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Effect of long-acting gonadotropin-releasing hormone analog (leuprolide) therapy on prostatic size and symptoms in 15 men with benign prostatic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Therapeutic controversies: clinical treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

The clinical effects of a 5 alpha-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900445-1

7 January 2021

10.1016/S0090-4295(96)00445-1

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

9037280

1 reference

13 January 2018